Establishment and characterization of a human malignant fibrous histiocytoma cell line. 1995

T Yonemoto, and T Takenouchi, and H Tokita, and S Tatezaki, and N Mukaida, and A Mikata, and H Moriya
Department of Orthopaedic Surgery, Chiba University, Japan.

Malignant fibrous histiocytoma is the most frequent soft tissue sarcoma. However, the pathogenesis still remains unclear, because there are very few human malignant fibrous histiocytoma cell lines available for precise cellular study. In this study, a human malignant fibrous histiocytoma cell line (MMF-1) was established from the pulmonary metastatic lesion of a 55-year-old man with malignant fibrous histiocytoma. Human cell line MMF-1 and its heterotransplanted tumor had almost the same characteristics as the original tumor morphologically and immunohistochemically. This cell line is expected to be a useful for studying the pathogenesis of malignant fibrous histiocytoma. The cloned cell lines (MMF-2 and MMF-3) also consisted of spindle-shaped, polygonal, and multinucleated giant cells, meaning that the fibroblast-like cells, histiocyte-like cells, and multinucleated giant cells seen in malignant fibrous histiocytoma were derived from a single tumor cell. Human cell line MMF-1 produced inflammatory cytokines, such as tumor necrosis factor-alpha, macrophage colony-stimulating factor, interleukin-8, and monocyte chemotactic and activating factor, that might be involved in the morphogenesis of malignant fibrous histiocytoma. Furthermore, the results of the analysis of human cell line MMF-1 suggested that malignant fibrous histiocytoma originated from a poorly differentiated fibroblast.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D003584 Cytological Techniques Methods used to study CELLS. Cytologic Technics,Cytological Technic,Cytological Technics,Cytological Technique,Technic, Cytological,Technics, Cytological,Technique, Cytological,Techniques, Cytological,Cytologic Technic,Technic, Cytologic,Technics, Cytologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014410 Tumor Stem Cell Assay A cytologic technique for measuring the functional capacity of tumor stem cells by assaying their activity. It is used primarily for the in vitro testing of antineoplastic agents. Clonogenic Cell Assay, Tumor,Colony-Forming Units Assay, Tumor,Neoplasm Stem Cell Assay,Stem Cell Assay, Tumor,Colony Forming Units Assay, Tumor

Related Publications

T Yonemoto, and T Takenouchi, and H Tokita, and S Tatezaki, and N Mukaida, and A Mikata, and H Moriya
August 2001, Pathology international,
T Yonemoto, and T Takenouchi, and H Tokita, and S Tatezaki, and N Mukaida, and A Mikata, and H Moriya
December 1990, Human cell,
T Yonemoto, and T Takenouchi, and H Tokita, and S Tatezaki, and N Mukaida, and A Mikata, and H Moriya
December 1995, Pathology, research and practice,
T Yonemoto, and T Takenouchi, and H Tokita, and S Tatezaki, and N Mukaida, and A Mikata, and H Moriya
April 1997, Cancer genetics and cytogenetics,
T Yonemoto, and T Takenouchi, and H Tokita, and S Tatezaki, and N Mukaida, and A Mikata, and H Moriya
June 1989, Human cell,
T Yonemoto, and T Takenouchi, and H Tokita, and S Tatezaki, and N Mukaida, and A Mikata, and H Moriya
December 2010, Journal of investigative surgery : the official journal of the Academy of Surgical Research,
T Yonemoto, and T Takenouchi, and H Tokita, and S Tatezaki, and N Mukaida, and A Mikata, and H Moriya
March 1991, Human cell,
T Yonemoto, and T Takenouchi, and H Tokita, and S Tatezaki, and N Mukaida, and A Mikata, and H Moriya
June 1985, Cancer,
T Yonemoto, and T Takenouchi, and H Tokita, and S Tatezaki, and N Mukaida, and A Mikata, and H Moriya
March 1998, The Tohoku journal of experimental medicine,
T Yonemoto, and T Takenouchi, and H Tokita, and S Tatezaki, and N Mukaida, and A Mikata, and H Moriya
January 2002, Journal of cancer research and clinical oncology,
Copied contents to your clipboard!